| Last updated
Children are set to take part in a new trial to test out the efficacy of the Oxford/AstraZeneca vaccine.
Researchers will use 300 volunteers aged between six and 17 to look at the immune response in the younger age groups.
Professor Andrew Pollard, chief investigator on the Oxford vaccine trial, said: "While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.
"These new trials will extend our understanding of control of SARS-CoV2 to younger age groups."
More to follow
Chosen for YouChosen for You
Most Read StoriesMost Read